T-regulatory Cells in ALS (NCT04055623)
Phase 2a Study of the Expansion and Infusion of Autologous T-Regulatory Cells in Amyotrophic Lateral Sclerosis
🩺 Plain-English Summary (8th-Grade Level)
This study is a randomized, placebo-controlled, phase 2a trial to study the biological activity, safety, and tolerability of regulatory T Lymphocytes (Tregs) taken and expanded outside of the body and returned back to the same person whose Treg were removed, given back by IV (intravenously) and in combination with low-dose IL-2 in people with Amyotrophic Lateral Sclerosis (ALS).
Who can join: Review the eligibility criteria below.
Location: Massachusetts General Hospital Neurological Clinical Research Institute — Boston, Massachusetts
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Massachusetts General Hospital Neurological Clinical Research Institute — Boston, Massachusetts
- Houston Methodist Hospital — Houston, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in ALS (Amyotrophic Lateral Sclerosis)
- Augmented Reality BCI Longitudinal Study for Persons With ALS, Stroke, TBI and SCI Utilizing Cognixion + Apple Vision Pro — Santa Barbara, California
- Tofersen in Non-SOD1 ALS — Atlanta, Georgia
- A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis — Leuven,
- Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS — Santa Barbara, California
- Tongue-strengthening Exercises in People With ALS. — Davie, Florida
Explore by condition: All ALS (Amyotrophic Lateral Sclerosis) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.